BRIEF published on 05/21/2024 at 14:55, 5 months 30 days ago Form 8.3 Disclosure: The Vanguard Group, Inc. - Anglo American plc Disclosure Takeover Code Vanguard Group Shareholding Anglo American
PRESS RELEASE published on 05/21/2024 at 14:50, 5 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% stake in Anglo American plc as of 20 May 2024. They made purchases of USD 0.54945 ordinary shares at 26.80 GBP and 27.00 GBP per unit The Vanguard Group, Inc. Financial Disclosure Share Purchases Stake Disclosure Anglo American PLC
BRIEF published on 05/20/2024 at 15:58, 6 months ago Vanguard Group Discloses Interest in Anglo American Plc Disclosure Takeover Code Vanguard Group Shareholding Anglo American
PRESS RELEASE published on 05/20/2024 at 15:53, 6 months ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.37% stake in Anglo American plc as of 17th May 2024 via Form 8.3. Additional disclosure for BHP Group Limited provided Form 8.3 The Vanguard Group Stake Disclosure Anglo American PLC BHP Group Limited
BRIEF published on 05/17/2024 at 16:28, 6 months 3 days ago Vanguard Group Reports Position in Anglo American plc Stock Trading Vanguard Group Share Ownership Market Regulation Anglo American PLC
PRESS RELEASE published on 05/17/2024 at 16:23, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% interest in Anglo American plc's relevant securities. Form 8.3 submitted to the Takeover Code The Vanguard Group, Inc. Form 8.3 Disclosure Takeover Code Anglo American PLC
BRIEF published on 05/16/2024 at 15:19, 6 months 4 days ago Vanguard Group Increases Stake in Anglo American plc Takeover Code Stock Purchase Vanguard Group Public Disclosure Anglo American PLC
PRESS RELEASE published on 05/16/2024 at 15:14, 6 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% stake in Anglo American plc. Form 8.3 filing on 16-May-2024 Form 8.3 Disclosure The Vanguard Group Inc. Stake Anglo American PLC
BRIEF published on 05/15/2024 at 14:59, 6 months 5 days ago The Vanguard Group Discloses Shareholding in Anglo American plc Vanguard Group Financial Disclosure Shareholding Mining Sector Anglo American PLC
PRESS RELEASE published on 05/15/2024 at 14:54, 6 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Anglo American plc The Vanguard Group, Inc. discloses a 4.38% stake in Anglo American plc through Form 8.3 with position disclosure details on USD 0.54945 ordinary shares Securities Form 8.3 The Vanguard Group Inc Stake Disclosure Anglo American PLC
Published on 11/21/2024 at 13:30, 17 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 17 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 47 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 47 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 47 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 12 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 32 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
